Immunotherapy before surgery shows promise for HPV throat cancer
NCT ID NCT06254911
First seen Jan 31, 2026 · Last updated May 16, 2026 · Updated 13 times
Summary
This study tests whether giving the immunotherapy drug atezolizumab before surgery can help treat HPV-related throat cancer that can be removed. About 20 adults with stage I oropharyngeal cancer will receive two doses of atezolizumab before their planned surgery. Researchers will monitor side effects, tumor shrinkage, and how long patients stay cancer-free.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNX CANCER, STAGE I are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University Hospital Midtown
Atlanta, Georgia, 30308, United States
Conditions
Explore the condition pages connected to this study.